CME Group Inc. (CME) Stock Forecast
CME analyst forecast
as of October 17, 2026- Analyst consensus
- Hold 3.47 / 5 from 17 analysts
- Price target
- $292.94 average of analyst targets
- Upside to target
- −0.3% from the latest close
- Next earnings
- October 21, 2026 EPS estimate $2.98
- 52-week range
- $218.58 – $326.46
CME analyst ratings
17 analystsNumber of analysts at each rating.
CME price target
The average of analyst 12-month price targets compared with the latest close and the 52-week range.
CME earnings per share estimates
| Period | Average | Low | High | Year ago | Growth | Analysts |
|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.98 | $2.90 | $3.07 | $2.68 | +11.3% | 14 |
| Current fiscal year (2026) | $12.31 | $12.11 | $12.53 | $11.20 | +9.9% | 16 |
| Next fiscal year (2027) | $13.00 | $12.10 | $13.60 | $12.31 | +5.7% | 16 |
Consensus EPS estimates; growth compares the average estimate with the year-ago EPS.
CME revenue estimates
| Period | Average | Low | High | Growth | Analysts |
|---|---|---|---|---|---|
| Current quarter (Sep '26) | $1.71B | $1.68B | $1.74B | +11.5% | 10 |
| Current fiscal year (2026) | $7.05B | $6.97B | $7.16B | +8.2% | 13 |
| Next fiscal year (2027) | $7.37B | $7.09B | $7.61B | +4.5% | 13 |
CME EPS: reported and forecast
Fiscal years; "E" marks estimates, the line shows the range from the lowest to the highest estimate.
CME revenue: reported and forecast
CME EPS estimate revisions
| Period | 90 days ago | 60 days ago | 30 days ago | 7 days ago | Now | Change (90 d) | Revisions (30 d) |
|---|---|---|---|---|---|---|---|
| Current quarter (Sep '26) | $2.96 | $2.94 | $2.94 | $2.96 | $2.98 | +0.6% | 7 up · 2 down |
| Current fiscal year (2026) | $12.17 | $12.27 | $12.25 | $12.27 | $12.31 | +1.1% | 8 up · 2 down |
| Next fiscal year (2027) | $12.85 | $12.93 | $12.93 | $12.96 | $13.00 | +1.2% | 8 up · 2 down |
How the consensus EPS estimate changed over the last 90 days, and how many analysts raised or lowered it in the last 30 days.
CME earnings surprises
Reported EPS vs the consensus estimate for the last 12 quarters; CME beat in 10 of 12.
What analysts expect from CME
17 analysts cover CME Group; their consensus rating is hold (3.47 on a 1–5 scale, where 5 is a strong buy). The average price target is $292.94, 0.3% below the latest close of $293.87. Analysts expect earnings of $12.31 per share for 2026, +9.9% from a year earlier. For 2027 the average estimate is $13.00 per share on revenue of $7.4 billion. CME Group beat the EPS estimate in 10 of the last 12 quarters.
Related: CME income statement, CME key metrics, CME chart. See the CME stock overview for the latest quote and news.
CME forecast FAQ
What is CME Group's price target?
The average analyst price target for CME Group is $292.94, 0.3% below the latest close of $293.87.
Is CME Group a buy, hold or sell?
Of 17 analysts covering CME Group, 4 rate it a strong buy, 4 a buy, 6 a hold, 2 a sell and 1 a strong sell, a consensus of hold. Ratings are opinions, not a recommendation from Quotelinks.
What is CME Group's EPS forecast?
Analysts forecast $12.31 per share for 2026 (range $12.11 to $12.53); for 2027 the estimate is $13.00.
What is CME Group's revenue forecast?
The average revenue estimate for 2026 is $7.1 billion, growth of 8.2%; for 2027 it is $7.4 billion.
When does CME Group report earnings?
CME Group is expected to report results for the quarter ending September 30, 2026 on October 21, 2026 before the market opens; the EPS estimate is $2.98.
Does CME Group usually beat earnings estimates?
CME Group reported EPS at or above the analyst estimate in 10 of the last 12 quarters.